Penumbra (PEN) Change in Receivables (2014 - 2026)
Penumbra's (PEN) quarterly Change in Receivables came in at -$5.5 million in Q1 2026, down 920.63% year-on-year from $675338.0 in Q1 2025, and down 181.21% on a QoQ basis from $6.8 million in Q4 2025.
Penumbra (PEN) Change in Receivables (2014 - 2026) Analysis & Trends
Penumbra (PEN) has 13 years of Change in Receivables data on file, last reported at -$5.5 million in Q1 2026.
- On a quarterly basis, Change in Receivables fell 920.63% year-over-year to -$5.5 million in Q1 2026; TTM through Mar 2026 was $14.5 million, a 177.7% increase from a year earlier, with the FY2025 full-year figure at $19.5 million, up 173.37% from the prior year.
- Change in Receivables for Q1 2026 stood at -$5.5 million, down from $6.8 million in the prior quarter.
- Over the last five years, Change in Receivables for PEN reached as high as $45.6 million in Q2 2022 and fell as low as -$25.4 million in Q3 2024.
- Historically, Change in Receivables has averaged $3.4 million across 5 years, with a median of $3.5 million in 2023.
- Across the five-year window, Change in Receivables surged 357.95% in 2022 and plunged 1301.43% in 2024, its largest moves.
- Year by year, Change in Receivables stood at $12.5 million in 2022, then plunged by 150.74% to -$6.3 million in 2023, then surged by 49.05% to -$3.2 million in 2024, then jumped by 311.14% to $6.8 million in 2025, then plunged by 181.21% to -$5.5 million in 2026.
- Per Business Quant data, the three most recent Change in Receivables figures were -$5.5 million in Q1 2026, $6.8 million in Q4 2025, and $8.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -124.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Penumbra | 12.48 Bn | 11.87 Bn | 253.41 Mn | -5.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.54 Mn |
| Mar 31, 2026 | -5.54 Mn |
| Dec 31, 2025 | 6.82 Mn |
| Dec 31, 2025 | 6.82 Mn |
| Sep 30, 2025 | 8.45 Mn |
| Sep 30, 2025 | 8.45 Mn |
| Jun 30, 2025 | 4.78 Mn |
| Jun 30, 2025 | 4.78 Mn |
| Mar 31, 2025 | -543,000.00 |
| Mar 31, 2025 | -543,000.00 |
| Dec 31, 2024 | -3.23 Mn |
| Dec 31, 2024 | -3.23 Mn |
| Sep 30, 2024 | -25.39 Mn |
| Sep 30, 2024 | -25.39 Mn |
| Jun 30, 2024 | 10.49 Mn |
| Jun 30, 2024 | 10.49 Mn |
| Mar 31, 2024 | -8.46 Mn |
| Mar 31, 2024 | -8.46 Mn |
| Dec 31, 2023 | -6.34 Mn |
| Dec 31, 2023 | -6.34 Mn |